This study will evaluate the effectiveness of switching medications in decreasing
schizophrenia symptoms in individuals who are currently taking an antipsychotic medication
for the treatment of schizophrenia.
This study will evaluate the effectiveness of switching medications in decreasing
schizophrenia symptoms in individuals who are currently taking an antipsychotic medication
for the treatment of schizophrenia.
A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
Completed
Janssen, LP
Phase 3
2004-05-01
The purpose of this study is to examine the safety and effectiveness of the long acting
injectable form of the atypical antipsychotic Risperidone (Risperdal CONSTA), along with
treatment as usual (TAU), in bipolar disorder patients who had more than 4 mood episodes in
the past year.
A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
Completed
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3
2004-05-01
The purpose of this study is to examine the safety and effectiveness of the long acting
injectable form of the atypical antipsychotic Risperidone (Risperdal CONSTA), along with
treatment as usual (TAU), in bipolar disorder patients who had more than 4 mood episodes in
the past year.
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Completed
Janssen, LP
Phase 4
2005-09-01
The purpose of this study is to compare the efficacy of oral risperidone (Risperdal) to
risperidone long-acting (Consta) in reducing alcohol use in persons diagnosed with
schizophrenia or schizoaffective disorder.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
